Role of Fexofenadine in Diabetic Kidney Disease

Status Completed

Clinical Trial Summary

- This study will that will be conducted on 60 outpatients previously diagnosed with type 2 diabetes mellitus. - Patients will be recruited from Internal Medicine Department, Tanta University Hospital, Tanta, Egypt. This study will be randomized, controlled, parallel, prospective clinical study. Accepted patients will be randomized into 2 groups as the following - Group 1 (Control group): 30 patients will receive maximum tolerated dose of ACEI for six months - Group 2 (Fexofenadine group): 30 patients will receive maximum tolerated dose of ACEI plus fexofenadine tablets 60 mg once daily for six months The primary end point will be the change in Urinary albumin to creatinine ratio (UACR) after six months of treatment

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04224428
Study type	Interventional
Source	Tanta University
Contact
Status	Completed
Phase	Phase 3
Start date	January 1, 2020
Completion date	February 1, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06006689` - Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis)	Phase 2
Enrolling by invitation	`NCT05530356` - Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
Completed	`NCT05086549` - An Observation Study to Evaluate the Renoprotective Effect of Fimasartan in Patients With DKD and Proteinuria
Recruiting	`NCT05008276` - Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
Completed	`NCT02276196` - Effect of LIXIsenatide on the Renal System	Phase 4
Not yet recruiting	`NCT06120569` - Evaluate the Role of Soleus Muscle Exercise in Glycaemic Control in Diabetic Kidney Disease Patients	N/A
Completed	`NCT02545049` - Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease	Phase 3
Active, not recruiting	`NCT02237352` - Mechanisms of Diabetic Nephropathy in Ecuador
Active, not recruiting	`NCT06176599` - Clinical Study on the Treatment of Diabetic Kidney Disease With Shenxiao Yuning Decoction With Syndrome of Qi and Yin Deficiency and Blood Stasis	N/A
Recruiting	`NCT03716401` - Prognostic Imaging Biomarkers for Diabetic Kidney Disease
Terminated	`NCT03840343` - Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease	Phase 1
Completed	`NCT01377688` - Personalized Diabetic Kidney Disease Risk Info to Initiate and Maintain Health Behavior Changes	N/A
Active, not recruiting	`NCT05514548` - Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease	Phase 2
Recruiting	`NCT05507892` - Renal Mechanism of SGLT2 Inhibition	Phase 2
Not yet recruiting	`NCT05514184` - Plant-Focused Nutrition in Patients With Diabetes and Chronic Kidney Disease	N/A
Not yet recruiting	`NCT06049550` - The Influence of the Thickening of Bowman's Capsule on the Clinical Prognosis of Patients With Diabetic Kidney Disease
Active, not recruiting	`NCT04589351` - Kidney Fat in Type 2 Diabetes and the Effects of Ezetimibe	Phase 3
Active, not recruiting	`NCT04531163` - Possible Ameliorating Effect of N- Acetylcysteine (NAC) on Type-II Diabetes Induced Nephropathy	Phase 2/Phase 3
Active, not recruiting	`NCT03620773` - Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes	Phase 1/Phase 2
Suspended	`NCT01878045` - Mechanisms of Diabetic Kidney Disease in American Indians